IMV Inc. (IMVIF)
IMVIF Stock Price Chart
Explore IMV Inc. interactive price chart. Choose custom timeframes to analyze IMVIF price movements and trends.
IMVIF Company Profile
Discover essential business fundamentals and corporate details for IMV Inc. (IMVIF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Apr 2013
Employees
63.00
Website
https://www.imv-inc.comCEO
Andrew Hall
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX, an immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
IMVIF Financial Timeline
Browse a chronological timeline of IMV Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2022
EPS came in at -$0.90 .
Stock split effective on 13 Dec 2022
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Sept 2022
EPS came in at -$1.02 .
Earnings released on 30 Jun 2022
EPS came in at -$1.19 .
Earnings released on 31 Mar 2022
EPS came in at -$1.30 .
Earnings released on 31 Dec 2021
EPS came in at -$1.42 .
Earnings released on 30 Sept 2021
EPS came in at -$1.31 .
IMVIF Stock Performance
Access detailed IMVIF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.